Concepedia

Olaf Hardt

OH

Statistics

Publications

22

Citations

1.2K

H-Index

17

Active since

2004

Affiliations

Miltenyi Biotec (Germany)(Current)

Universitätsmedizin Göttingen

Max Planck Institute of Experimental Medicine

German Cancer Research Center

Heidelberg University

Olaf Hardt is an author at Miltenyi Biotec (Germany) specializing in oncology, medicine, and life sciences.

ORCID

Publications per year

2004–2025

22

Publications

22

NeuroD1 induces terminal neuronal differentiation in olfactory neurogenesis

Camille Boutin, Olaf Hardt, Antoine de Chevigny et al. · Proceedings of the National Academy of Sciences · 2009 · 170 citations · Full text

, , +17

MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors

Ali Kinkhabwala, Christoph Herbel, Jennifer Pankratz et al. · Scientific Reports · 2022 · 140 citations · Full text

, , +17

Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use

Dominik Lock, Nadine Mockel-Tenbrinck, Katharina Drechsel et al. · Human Gene Therapy · 2017 · 113 citations · Full text

, , +17

Characterization of Peptides Released from Mitochondria

Steffen Augustin, Mark Nolden, Stefan Müller et al. · Journal of Biological Chemistry · 2004 · 95 citations · Full text

, , +10

Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma

Daniel Schäfer, Stefan Tomiuk, Laura N. Küster et al. · Nature Communications · 2021 · 87 citations · Full text

, , +17

1–5 of 22